Antoney J. Ferrey
Biography
Antoney J. Ferrey, M.D., FASN, is a Health Sciences Assistant Clinical Professor in the Division of Nephrology, Hypertension, & Kidney Transplantation in the Department of Medicine at the University of California, Irvine. He serves as Medical Director of Inpatient & Emergent Dialysis at UCI Health and Medical Director of Living Donor Kidney Transplant. Ferrey received his M.D. from The Ohio State University College of Medicine, completed his internal medicine residency at LAC+USC Medical Center/University of Southern California, and completed his nephrology fellowship at Nephrology Specialist Medical Group in Orange, California.
Ferrey has published over 30 peer-reviewed articles in nephrology and transplantation, with research interests spanning dialysis management, kidney transplantation, and COVID-19 in kidney disease populations. His early work included molecular genetics research on E2F transcription factors published in Nature. His clinical research has examined dialysate potassium and mortality in hemodialysis patients, COVID-19 in dialysis and transplant populations, and outcomes in undocumented immigrant kidney transplant recipients. He serves as principal investigator on a study assessing acute and chronic kidney disease incidence and outcomes in patients with COVID-19 infection and as co-principal investigator on the UCI Living Kidney Donor Registry and Outcomes Improvement project.
Ferrey served as Associate Program Director for the Nephrology Fellowship at UCI from 2022 to 2024 and has delivered numerous lectures on topics including acute kidney injury, kidney transplantation, and COVID-19 management in vulnerable populations. He is a Fellow of the American Society of Nephrology and serves as a board member for CKCC, Strive Health, and KCE of Southern California. Ferrey is fluent in both English and Spanish.
Return to topEducation
- MD, The Ohio State University College of Medicine, 2012
- BS in Biology, The Ohio State University, 2009
Distinctions
- Fellow of American Society of Nephrology (FASN)
- Research Distinction in Molecular Genetics, The Ohio State University, 2009
- Suma Cum Laude, The Ohio State University, 2009
- DOM Chair's QI/HEOR Award for UCI Living Kidney Donor Registry and Outcomes Improvement, 2024
- Excellence In Teaching Award, UCI SOM, Division of Nephrology, Hypertension, & Kidney Transplantation, 2023
Areas of Expertise
- Kidney Transplantation
- Dialysate Potassium Mortality
- COVID-19 Hemodialysis Complications
- Thrombotic Microangiopathy Syndromes
- Hypertension Management Post-Transplant
- Living Kidney Donor Outcomes
- Nrf2 Pathway Diabetic Nephropathy
Recent Publications
- Tantisattamo E, Ferrey AJ, Reddy UG, Redfield RR 3rd, Ichii H, Al Ammary F, Lau WL, “Diagnostic and therapeutic challenges in implementing hypertension management after kidney transplantation” (opens in new tab), Current Opinion in Nephrology and Hypertension, vol. 34, no. 1, pp. 4-15, 2025.
- Tantisattamo E, Ferrey AJ, Reddy UG, Malik FT, Siu MKM, Ammary FA, Lau WL, “A paradigm shift from office to home-based blood pressure measurement approaches in kidney transplant recipients” (opens in new tab), Current Opinion in Nephrology and Hypertension, vol. 33, no. 1, pp. 67-76, 2024.
- Mahatanan R, Tantisattamo E, Charoenpong P, Ferrey A, “Outcomes of C difficile infection in solid-organ transplant recipients: The National Inpatient Sample (NIS) 2015-2016” (opens in new tab), Transplant Infectious Disease, vol. 23, no. 1, pp. e13459, 2021.
- Hanna RM, Ferrey A, Rhee CM, Sam R, Pearce D, Kalantar-Zadeh K, Don BR, “Building a hemodiafiltration system from readily available components for continuous renal replacement therapy under disasters and pandemics: preparing for an acute kidney injury surge during COVID-19” (opens in new tab), Current Opinion in Nephrology and Hypertension, vol. 30, no. 1, pp. 93-96, 2021.
- Ferrey AJ, Hanna R, Reddy UG, Tantisattamo E, Kalantar-Zadeh K, Amin AN, “Novel therapeutic approaches for COVID-19 in chronic kidney disease and transplant” (opens in new tab), Current Opinion in Nephrology and Hypertension, vol. 30, no. 1, pp. 47-53, 2021.
- Ivaturi K, Ferrey AJ, Nguyen L, Tonthat S, Kohli S, Torres EA, Kalantarzadeh K, Hanna R, “Metabolic acidosis due to ingestion of lanthanum sulfates and chlorides in cetyl alcohol solution pool cleaner” (opens in new tab), Clinical Case Reports, vol. 9, no. 5, pp. e04121, 2021.
Most Cited Publications
- Ferrey AJ, Choi G, Hanna RM, Chang Y, Tantisattamo E, Ivaturi K, Park E, Nguyen L, Wang B, Tonthat S, Rhee CM, Reddy U, Lau WL, Huang SS, Gohil S, Amin AN, Hsieh L, Cheng TT, Lee RA, Kalantar-Zadeh K, “A Case of Novel Coronavirus Disease 19 in a Chronic Hemodialysis Patient Presenting with Gastroenteritis and Developing Severe Pulmonary Disease” (opens in new tab), American Journal of Nephrology, vol. 51, no. 5, pp. 337-342, 2020.
- Ferrey A, You AS, Kovesdy CP, Nakata T, Veliz M, Nguyen DV, Kalantar-Zadeh K, Rhee CM, “Dialysate Potassium and Mortality in a Prospective Hemodialysis Cohort” (opens in new tab), American Journal of Nephrology, vol. 47, no. 6, pp. 415-423, 2018.
- Hanna RM, Ferrey A, Rhee CM, Kalantar-Zadeh K, “Renal-Cerebral Pathophysiology: The Interplay Between Chronic Kidney Disease and Cerebrovascular Disease” (opens in new tab), Journal of Stroke and Cerebrovascular Diseases, vol. 30, pp. 105461, 2020.
- Tantisattamo E, Ferrey AJ, Reddy UG, Ichii H, Dafoe DC, Kalantar-Zadeh K, “Haddon matrix for kidney transplantation during COVID-19 pandemic: A problem solving framework for present and future” (opens in new tab), Transplant Infectious Disease, vol. 22, no. 6, pp. e13373, 2020.
This profile was created with the help of AI.
Last updated on 3/12/2026.